Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.hpb.2022.09.006 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Long-term outcomes after breast cancer liver metastasis surgery: A European, retrospective, snapshot study (LIBREAST STUDY).
Surg Oncol
December 2024
Department of Surgery, Hospital Universitario Virgen de Las Nieves, Instituto de Investigación Biosanitaria Ibs.GRANADA, School of Medicine, University of Granada, Granada, Spain.
Article Synopsis
- Breast cancer is prevalent among women, with 20-30% of patients developing metastases, primarily affecting the liver. Patients with liver metastases have a wide range of survival rates, influenced by various factors.
- This study aimed to assess the long-term survival and disease-free outcomes for patients who had surgery for liver metastases stemming from breast cancer.
- Results indicated that surgery can enhance long-term survival, with specific patient characteristics (like health status, hormone receptor positivity, and prior treatments) linked to improved outcomes.
Surgical management of pancreatic neuroendocrine tumors - An EYSAC and E-AHPBA international survey of current practice.
Eur J Surg Oncol
October 2024
Department of General, Visceral and Vascular Surgery, Salzkammergutklinikum, Vöcklabruck, Austria.
Introduction: Pancreatic neuroendocrine tumors (pNET) exhibit a wide spectrum of clinical behavior, which makes their assessment and management quite challenging. The purpose of this study was to comprehensively assess the existing treatment landscape for patients with pNET.
Materials And Methods: The study was conducted with the support of the ESSO-EYSAC Research Academy in collaboration with the E-AHPBA.
Is it resectable? A survey regarding tumor classification and vascular involvement.
HPB (Oxford)
May 2024
University of Alabama at Birmingham, Birmingham, United States.
Introduction: The anatomic location of the pancreas can result in involvement of major vasculature, which may act as a contraindication to resection. Several classification systems have been developed. We sought to discover the variations in the HPB community determining PDAC resectability.
View Article and Find Full Text PDFImplementation and outcome of minimally invasive pancreatoduodenectomy in Europe: a registry-based retrospective study - a critical appraisal of the first 3 years of the E-MIPS registry.
Int J Surg
April 2024
Department of General Surgery, Istituto Ospedaliero Fondazione Poliambulanza, Brescia.
Article Synopsis
- There is a lack of international studies on the outcomes of minimally invasive pancreatoduodenectomy (MIPD), prompting the establishment of the European Registry for Minimally Invasive Pancreatic Surgery (E-MIPS) to monitor these procedures in Europe.
- An analysis of 1,336 patients from 45 centers across 14 European countries indicated significant outcomes, including a major morbidity rate of 41.2% and a 30-day/in-hospital mortality rate of 4.5%.
- Findings revealed that robot-assisted MIPD (R-MIPD) is becoming more popular than laparoscopic MIPD (L-MIPD), with better outcomes in terms of major morbidity and lower rates of complications when performed
Introduction to AHPBA fellowship training strength, weaknesses, opportunities, and threats (SWOT) analysis.
HPB (Oxford)
December 2022
Department of Surgery, Mayo Clinic, Rochester, MN, USA. Electronic address:
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!